Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Transplant Proc ; 52(8): 2539-2543, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32591136

ABSTRACT

A 42-year-old woman received a simultaneous pancreas and kidney transplantation (SPK). Immunosuppression consisted of tacrolimus modified release, prednisone, mycophenolate mofetil (MMF), and thymoglobulin as induction. The function of both grafts was good. Eight months after SPK, the patient suffered from weakness and arthralgia. Normocytic anemia with reticulocytopenia was revealed. In a bone marrow examination, giant pronormoblasts were found. Immunohistochemical staining of bone marrow and serum examination were positive for Parvovirus B19 (Parvo B19) confirming diagnosis of pure red cell aplasia (PRCA).The treatment consisted of MMF withdrawal, red-cell transfusions, immunoglobulins subcutaneously (SCIg) and immunosuppression reduction. Rapid improvement was observed with the rise of reticulocyte count and hemoglobin. Two months after the achievement of remission, the low dose of everolimus was added considering the high risk of rejection and antiviral potential of mTOR inhibitors. Three months later, PRCA relapsed. Retherapy with SCIg was still effective. Subsequent SCIg was supplemented due to low reticulocyte count and recurrent herpes zoster. The replication of Parvo B19 was persistent (serum qualitative test). Everolimus was withdrawn after 9 months of therapy due to the recurrence of PRCA and serious infections. The observation period after PRCA diagnosis lasts for 15 months. The patient is in good condition with no anemia and excellent grafts function. In conclusion, pure red cell aplasia related to Parvo B19 infection should be considered in transplant recipients with normocytic anemia and reticulocytopenia. The treatment with immunoglobulin G and immunosuppression reduction is an effective therapy. The role of everolimus in Parvo B19 infection requires future studies.


Subject(s)
Immunosuppression Therapy/adverse effects , Parvoviridae Infections/immunology , Parvovirus B19, Human/immunology , Postoperative Complications/immunology , Red-Cell Aplasia, Pure/virology , Adult , Female , Humans , Immunoglobulins/therapeutic use , Kidney Transplantation/adverse effects , Pancreas Transplantation/adverse effects , Parvoviridae Infections/drug therapy , Parvoviridae Infections/virology , Postoperative Complications/drug therapy , Postoperative Complications/virology , Red-Cell Aplasia, Pure/drug therapy
2.
Pol J Microbiol ; 67(1): 89-96, 2018 Mar 09.
Article in English | MEDLINE | ID: mdl-30015429

ABSTRACT

As a complement to the active search for cases of acute flaccid paralysis, environmental sampling was conducted from January to December 2011, to test for any putative polio revertants and recombinants in sewage. A total of 165 environmental samples were obtained and analyzed for the presence of polioviruses by use of cell culture (L20B, RD and Caco-2) followed by neutralization and reverse-transcription polymerase chain reaction. Out of the 31 CPE positive samples, 26 contained one and 5 two different serotypes, yielding a total of 36 PVs. The microneutralization test revealed the presence of 7, 10 and 19 strains belonging to poliovirus serotype 1, 2 and 3, respectively. The genomic variability of 36 poliovirus strains was examined by the restriction fragment length polymorphism assay (RFLP). By combined analyses of two distant, polymorphic segments of the viral genome, one situated in the capsid protein VP1 coding region and the other in the 3D-polymerase coding region, we screened for the putative poliovirus revertants and recombinants. All detected PVs were classified as vaccine strains on the basis of RFLP-VP1 test. None of wild-type PVs or vaccine derived polioviruses were detected. RFLP assay also revealed the presence of 11 recombinants in 3D-polymerase coding region. Nine isolates appeared to be S3/S2, one S3/S1 and S1/S2 recombinant in analyzed 3Dpol region. This study revealed, through environmental monitoring, the introduction of SL PVs into the population associated with the routine use of OPV in Poland before the April 2016. Our findings demonstrate the usefulness of environmental surveillance in the overall polio eradication program.


Subject(s)
Environmental Monitoring , Poliovirus/genetics , Poliovirus/isolation & purification , Sewage/virology , Capsid Proteins/genetics , Genome, Viral , Humans , Neutralization Tests , Poland , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Sequence Analysis, DNA , Serogroup
3.
Food Environ Virol ; 7(3): 224-31, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25862480

ABSTRACT

The aim of this study was to apply environmental surveillance to evaluate circulation of non-polio enteroviruses (NPEVs) in sewage in Poland. Samples of raw sewage were collected in 14 sewage disposal systems from January to December, 2011. Sewage samples were concentrated prior to analysis by RT-PCR and isolation in cells (RD, L20B and Caco-2). Out of the 165 analysed samples, 127 (77%) were positive for enteroviruses using RT-PCR and 109 (66%) were positive for enteroviruses using cell culture methods and the highest detection rate was observed in the summer and autumn. In total, 141 enteroviruses were identified using neutralization test (107 NPEVs and 34 polioviruses). Accounting for 52% of all the detected NPEVs, E11 and E3 were the predominant serotypes identified in raw sewage. Retrospectively, E11 was the known aetiology for the past aseptic meningitis outbreaks in Poland, as E3 being rarely associated with any outbreak prior to 2013. In conclusion, the environmental surveillance provides data which may help in understanding the epidemiology of enteroviruses in humans.


Subject(s)
Enterovirus/isolation & purification , Environmental Monitoring , Sewage/virology , Cell Line , Enterovirus/classification , Enterovirus/genetics , Humans , Poland , Seasons , Serogroup
4.
Przegl Epidemiol ; 65(1): 71-4, 2011.
Article in Polish | MEDLINE | ID: mdl-21735840

ABSTRACT

The aim of this study was to determine the frequency of each genotype of papillomavirus caused infection in human. In the years 2007-2009 in NIPH-NIH diagnostic tests were carried out, among 250 participants (222 women and 25 men). The samples were tested by PCR and subsequently LiPA hybridization was performed. Positive results were obtained in 66.4% and negative in 27.2% of all examined cases. In 30.0% of the examined cases only one genotype was detected. Mixed infections were diagnosed in 32.0% (of cases from one person). In mixed infections two (15.6% of tested patients), three (11.6%), four (4.4%) and even five genotypes were detected. HPV 51 was the most frequently detected type (in over 20% of cases), followed by HPV 66 (in 14%) and HPV 11 (over 11%). The genotypes 43 and 80 were not detected. HPV 17 and HPV18 types were confirmed in 7.6% and 4.8% of all tested cases.


Subject(s)
DNA, Viral/isolation & purification , Papillomaviridae/classification , Papillomaviridae/isolation & purification , Papillomavirus Infections/diagnosis , Papillomavirus Infections/epidemiology , Adolescent , Adult , DNA, Viral/genetics , Female , Genotype , Humans , Male , Middle Aged , Nucleic Acid Hybridization/genetics , Papillomaviridae/genetics , Papillomavirus Infections/virology , Poland/epidemiology , Polymerase Chain Reaction , Population Surveillance , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...